Drugs / Rotigexole
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07015346 | Sep → Oct 2025 overdue | Parkinson disease | Eva Pharma | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rotigexole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07015346 ↗ |
| Route | Other | “transdermal patch” NCT07015346 ↗ |